AIIMS breakthrough may lead to world's first oral Hepatitis
AIIMS breakthrough may lead to world's first oral Hepatitis B vaccine
Researchers at the All India Institute of Medical Sciences (AIIMS) have developed nano-particles loaded with antigen protein segments that could lead to the discovery of an oral hepatitis B vaccine.
“The outcomes are positive in animal studies and if human trials are successful as well, an oral vaccine for hepatitis B could become a reality by 2021, doing away with the need for injections and booster doses,” said Dr Amit Dinda, professor of pathology at the AIIMS, who led the research.
Read more:
http://www.hindustantimes.com/delhi/aiims-breakthrough-may-lead-to-world-s-first-oral-hepatitis-b-vaccine/story-H3bkj3LmVWvUxUYRkM0NNL.html
Dr. M●●●●●●●●m T●●. and 1 others like this
Like
Comment
Share